Versus other EGFR inhibitors, osimertinib showed longer progression free survival time
Osimertinib for EGFR Non small cell carcinoma
Published by Xyberdoc
An Integrative doctor specializing in cancer therapies emphasizing on orthomolecular therapies, acupuncture, homeopathy, energy medicine. I do online medical consultation thru skype, facetime or mobile phone, should you wish to seek more medical information. View all posts by Xyberdoc
Published